Skip to content

Based on the theory of dampness toxicity of spleen deficiency and microecology, the molecular mechanism of the immune regulation of CRC by the combination of Zhengqi Liujun Cancer Suppression Decoction and Zhengqi Powder was discussed

Based on the theory of dampness toxicity of spleen deficiency and microecology, the molecular mechanism of the immune regulation of CRC by the combination of Zhengqi Liujun Cancer Suppression Decoction and Zhengqi Powder was discussed

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003574
Enrollment
Unknown
Registered
2020-08-16
Start date
2020-08-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Sponsors

The Traditional Chinese Medicine Hospital Affiliated to Southwest
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 74 Years

Inclusion criteria

Inclusion criteria: (1) Patient was diagnosed as CRC by pathological examination at the first or second visit; (2) Patients without postoperative chemoradiotherapy; (3) According to the 3rd edition of Internal Medicine of Traditional Chinese Medicine edited by Xue Boyu and Wu Wei, combining years of clinical experience of doctors, syndrome differentiation was characterized by spleen deficiency and dampness syndrome; (4) Eastern Cooperative Oncology Group (ECOG) score 3 months; (5) Patients with 18 ? age ?74 years old; No gender restriction; (6) Voluntarily enrolled, able to cooperate with research and inspection and sign informed consent; * Note: Criterion 1 must be met.

Exclusion criteria

Exclusion criteria: (1) Patients with inflammatory bowel disease (IBD), hemorrhoids, etc. (2) Unable to cooperate, such as the combination of neurological and mental disorders. (3) Patients after intestinal ostomy. (4) Microecological regulators used in the past two weeks. (5) Patients with severe respiratory, circulatory, urinary, neurological, digestive, hematopoietic system and metabolic diseases are allergic to the Traditional Chinese medicine used in the study. (6) Women during pregnancy. (7) Other researchers should not participate in the clinical research according to the judgment of the researcher.

Design outcomes

Primary

MeasureTime frame
Intestinal flora 16SRDNA sequencing;Peripheral blood PD-1 and PD-L1;

Secondary

MeasureTime frame
survival time;Quality of life;Adverse events;

Countries

China

Contacts

Public ContactZhongming Yang

The Traditional Chinese Medicine Hospital Affiliated to Southwest

brainyang@swmu.edu.cn+86 18583079580

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026